Keyphrases
Mortality Risk
100%
Infection Risk
100%
Radiation Therapy
100%
Associated Risk
100%
Thoracic Region
100%
Radiation-induced Lymphopenia
100%
Thoracic Tumor
80%
Lymphocyte Count
80%
Clinical Outcomes
60%
Lymphopenia
60%
Heart Dose
60%
Best Model
40%
Patients with Breast Cancer
40%
Dose-volume Histogram
40%
AIMS™
20%
Radiotherapy
20%
Treatment Failure
20%
Blood Volume
20%
Overall Survival
20%
Cancer Treatment
20%
Esophageal Cancer
20%
Radiation Exposure
20%
Circulating Lymphocytes
20%
Individualized Dosing
20%
Nomogram
20%
Small Cell Lung Cancer
20%
Non-small Cell Lung Cancer (NSCLC)
20%
Dosimetric
20%
Lower End
20%
Goodness-of-fit
20%
Clinical Predictors
20%
Dosimetric Parameters
20%
Peripheral Lymphocytes
20%
Multivariate Linear Regression
20%
Concomitant Chemotherapy
20%
Clinical Systems
20%
Collaborative Deep Learning
20%
Heart Dosimetry
20%
Medicine and Dentistry
Infection
100%
Radiation Therapy
100%
Chest
100%
Lymphocytopenia
100%
Lymphocyte
83%
Thorax Tumor
66%
Breast Cancer
33%
Dose-Volume Histogram
33%
Low Drug Dose
16%
Radiation Exposure
16%
Non Small Cell Lung Cancer
16%
Overall Survival
16%
Cancer Therapy
16%
Linear Regression Analysis
16%
Dosimetry
16%
Esophageal Cancer
16%
Small Cell Lung Cancer
16%
Clinical Predictor
16%
Cancer Radiotherapy
16%
Peripheral Lymphocyte
16%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Lymphocytopenia
100%
Thorax Tumor
80%
Breast Cancer
40%
Dose-Volume Histogram
40%
Malignant Neoplasm
20%
Overall Survival
20%
Chemotherapy
20%
Dosimetry
20%
Non Small Cell Lung Cancer
20%
Esophagus Cancer
20%
Small Cell Lung Cancer
20%
Radiation Exposure
20%